logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Kangchen Pharmaceutical (01681.HK) spent approximately HK$2.9692 million on November 11 to repurchase 200,000 shares.

date
11/11/2025
Zhixin Finance APP news, Healthade Pharmaceutical (01681.HK) announced that on November 11, 2025, it will spend approximately 2.9692 million Hong Kong dollars to repurchase 200,000 shares.
Latest
2 m ago
Energy-saving National Zhen (300388.SZ) plans to repurchase shares with an amount of 50 million to 100 million yuan.
2 m ago
German Commercial Bank: If official data reveals weakness, the US dollar may weaken.
2 m ago
China Resources Vanguard (00007.HK) appointed Song Junhua as an executive director.
3 m ago
Qingshuiyuan: The administrative approval for part of the 20,000 ton/year phosphorus pentachloride project in the company relocation project has not been obtained.
3 m ago
The collapse of the Red Flag Bridge in the city of Barkam, Sichuan Province was caused by the intensified deformation of the mountainside, resulting in a landslide.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.